Related Experiment Video
Updated: Dec 12, 2025
06:07
Evaluating Cell Death Using Cell-Free Supernatant of Probiotics in Three-Dimensional Spheroid Cultures of Colorectal Cancer Cells
Published on: June 13, 2020
7.0K
Probiotics and Covid-19
Benedetta Bottari1, Vincenzo Castellone1, Erasmo Neviani1
1Department of food and drug, University of Parma, Parma, Italy.
International Journal of Food Sciences and Nutrition
|August 14, 2020
Summary
Probiotics may help manage coronavirus disease 2019 (COVID-19) by addressing gut microbiota dysbiosis and leveraging the lung-gut axis. This review compiles current information on probiotics for COVID-19 prevention and treatment.
Area of Science:
- Microbiology
- Immunology
- Gastroenterology
Background:
- The rapid global spread of COVID-19 necessitates exploring novel therapeutic strategies.
- Probiotics have been suggested for COVID-19 based on indirect evidence and their known effects on viral respiratory infections.
- Emerging research highlights a "lung-gut axis," linking gut health to respiratory conditions.
Purpose of the Study:
- To consolidate existing research on the role of probiotics in COVID-19.
- To provide a foundation for future investigations into probiotic interventions for COVID-19.
Main Methods:
- Systematic review of current literature on probiotics and COVID-19.
- Analysis of studies investigating gut microbiota dysbiosis in COVID-19 patients.
- Examination of the lung-gut axis in the context of viral respiratory diseases.
Main Results:
- COVID-19 is associated with intestinal microbiota dysbiosis.
- Probiotics show potential efficacy in managing viral respiratory tract infections.
- The lung-gut axis provides a theoretical basis for probiotic use in COVID-19.
Conclusions:
- Probiotic administration is a potential therapeutic avenue for COVID-19.
- Modulating gut microbiota may be a viable strategy for COVID-19 prevention and treatment.
- Further research is needed to elucidate the specific roles and efficacy of probiotics in severe COVID-19.
Related Concept Videos
01:29Microorganisms in Medicine and Therapeutics
758
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
758
01:26Factors Affecting the Risk of Infection
13.1K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.1K
01:29Bacterial Flora of the Large Intestine
1.2K
The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
1.2K
01:18Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
338
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
338
01:17Drugs for Treatment of Diarrhea-Predominant IBS
494
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
494
01:50What is Monogastric Digestion?
74.6K
The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
74.6K